ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Patrick J Heron bought $34K of Arcutis Biotherapeutics, Inc.
Bought$34,317
$13.62Price
2,520Shares
What ARQT did for a copier
- $1,000 copied at Tue, May 20 open, $14.70
- $940
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Jul 3 close.
Patrick J Heron's record
15 other buys with 3 months of prices since 2020: on average +6.3% against the S&P 500, and 10 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 15. Filed Mon, May 19, 4:14 PM ET, after the close. Returns use the May 20 open and the Jul 3 close. Not investment advice.